CPR logo

Davide Campari-Milano N.V. Stock Price

BIT:CPR Community·€6.5b Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 67 Fair Values set on narratives written by author

CPR Share Price Performance

€5.45
-0.24 (-4.22%)
€7.06
Fair Value
€5.45
-0.24 (-4.22%)
22.9% undervalued intrinsic discount
€7.06
Fair Value
Price €5.45
AnalystConsensusTarget €7.06
AnalystLowTarget €5.30
AnalystHighTarget €9.21

CPR Community Narratives

·
Fair Value €7.06 22.9% undervalued intrinsic discount

US, APAC And EMEA Expansion Will Open New Markets

0users have liked this narrative
1users have commented on this narrative
36users have followed this narrative
·
Fair Value €5.3 2.8% overvalued intrinsic discount

Falling Alcohol Consumption And Rising Costs Will Undermine Value

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value €9.21 40.9% undervalued intrinsic discount

Premiumization And Mixology Trends Will Expand Global Spirits Markets

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
€5.3
2.8% overvalued intrinsic discount
Revenue
1.44% p.a.
Profit Margin
12.65%
Future PE
20.12x
Price in 2029
€6.79
€7.06
22.9% undervalued intrinsic discount
Revenue
3.33% p.a.
Profit Margin
13.88%
Future PE
23.01x
Price in 2029
€9.02

Trending Discussion

Updated Narratives

CPR logo

CPR: Mixed Q1 Delivery And Tariff Headwinds Will Test Higher P E Assumptions

Fair Value: €5.3 2.8% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CPR logo

CPR: Higher Dividend Visibility And Improved Margin Outlook Will Support Constructive Re Rating

Fair Value: €9.21 40.9% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CPR logo

CPR: Higher Future P/E Assumptions Will Support Upside Repricing

Fair Value: €7.06 22.9% undervalued intrinsic discount
36 users have set this as their fair value
1 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet established dividend payer.

2 Risks
5 Rewards

Davide Campari-Milano N.V. Key Details

€3.1b

Revenue

€1.2b

Cost of Revenue

€1.8b

Gross Profit

€1.5b

Other Expenses

€346.3m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Jul 29, 2026
0.29
60.31%
11.35%
68.0%
View Full Analysis

About CPR

Founded
1860
Employees
4807
CEO
Simon Hunt
WebsiteView website
www.camparigroup.com

Davide Campari-Milano N.V., together with its subsidiaries, trades in alcoholic and non-alcoholic beverages in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers a range of products, including aperitifs, vodka, whisky, rum, agave, cognac, and champagne under the Aperol, Campari, Picon, Cynar, Sarti Rosa, Campari Soda, Crodino, Aperol Spritz RTE, Wild Turkey, Appleton Estate, Wray and Nephew, The GlenGrant, Wilderness Trail, Espolòn, Ancho Reyes, Montelobos, Grand Marnier, Courvoisier, Bisquit, Champagne Lallier, SKYY Vodka, Bulldog Gin, Averna, Braulio, Forty Creek, Frangelico, Cabo Wabo, Del Professore, Mondoro, Riccadonna, La Mauny, Trois Rivieres, Kingston 62, O’ndina, Bickens, Dreher, Ouzo 12, Sagabita, and Zedda Piras brand names. Davide Campari-Milano N.V. was founded in 1860 and is headquartered in Sesto San Giovanni, Italy. Davide Campari-Milano N.V. operates as a subsidiary of Lagfin S.C.A.

Recent CPR News & Updates

Narrative Update Jun 04

CPR: Mixed Q1 Delivery And Tariff Headwinds Will Test Higher P E Assumptions

Analysts have trimmed their average price target on Davide Campari-Milano by €0.25. This reflects updated views on the stock after recent target cuts from Citi and RBC that partly offset earlier increases from both firms.

Recent updates

No updates